ACUT — ACCUSTEM SCIENCES Balance Sheet
0.000.00%
Last trade - 00:00- $3.35m
- $3.39m
Annual balance sheet for ACCUSTEM SCIENCES, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|
| Period Length: | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Cash and Equivalents | ||||
| Cash and Short Term Investments | — | — | 0.734 | 0.021 |
| Net Total Receivables | 1.37 | 1.35 | 0 | — |
| Prepaid Expenses | ||||
| Total Other Current Assets | ||||
| Total Current Assets | 1.37 | 1.35 | 0.932 | 0.13 |
| Gross Property, Plant And Equipment | ||||
| Accumulated Depreciation | ||||
| Net Property, Plant And Equipment | — | — | 0.008 | 0.004 |
| Total Assets | 1.37 | 1.35 | 0.94 | 0.134 |
| Accounts Payable | ||||
| Accrued Expenses | ||||
| Notes Payable / Short Term Debt | ||||
| Total Other Current Liabilities | ||||
| Total Current Liabilities | 0.055 | 0.703 | 1.08 | 2.25 |
| Total Long Term Debt | ||||
| Total Debt | ||||
| Total Liabilities | 0.055 | 0.703 | 1.08 | 2.25 |
| Common Stock | ||||
| Additional Paid In Capital | ||||
| Retained Earnings (Accumulated Deficit) | ||||
| Other Equity | ||||
| Total Equity | 1.31 | 0.651 | -0.14 | -2.11 |
| Total Liabilities & Shareholders' Equity | 1.37 | 1.35 | 0.94 | 0.134 |
| Total Common Shares Outstanding |